DISCLOSEDQuarterly
Renaissance Technologies
Relmada Therapeutics Inc · NASDAQ
167,200 sh · $1.2M
Filed 31 Mar 2026SEC 13Fview source
Renaissance Technologies
Relmada Therapeutics Inc · NASDAQ
167,200 sh · $1.2M
Two Sigma Investments
Relmada Therapeutics Inc · NASDAQ
408,095 sh · $2.8M
BlackRock
Relmada Therapeutics Inc · NASDAQ
573,314 sh · $1.7M